SelectQuote, Inc. (SLQT)
After hours:
| Previous close | 1.6100 |
| Open | 1.6400 |
| Bid | 1.7800 x 2900 |
| Ask | 1.7900 x 2200 |
| Day's range | 1.6350 - 1.8100 |
| 52-week range | 1.0300 - 2.3950 |
| Volume | |
| Avg. volume | 742,245 |
| Market cap | 304.189M |
| Beta (5Y monthly) | 0.69 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
SelectQuote to Release Fiscal Third Quarter 2024 Earnings on May 9; Will Present at RBC’s Global Healthcare Conference on May 15
OVERLAND PARK, Kan., May 01, 2024--SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of an emerging Healthcare Services platform, today announced the date for the release of its third quarter financial results and upcoming RBC conference presentation.
- Business Wire
SelectQuote, Inc. Reports Second Quarter 2024 Results
OVERLAND PARK, Kan., February 07, 2024--SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue for the second quarter of fiscal year 2024 of $405.4 million, compared to consolidated revenue for the second quarter of fiscal year 2023 of $319.2 million. Consolidated net income for the second quarter of fiscal year 2024 was $19.4 million, compared to consolidated net income for the second quarter of fiscal year 2023 of $22.5 million. Finally, consolidated Adjusted EBITDA* for the second quart
- Business Wire
SelectQuote to Release Fiscal Second Quarter 2024 Earnings on February 7
OVERLAND PARK, Kan., January 23, 2024--SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of an emerging Healthcare Services platform, announced today that it will release its fiscal second quarter 2024 financial results prior to market open on Wednesday, February 7, 2024. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (February 7, 2024) at 8:30 am ET to discuss the
